TickerFactsScreenerDevelopers

Anixa Biosciences Inc (ANIX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $1.45M2010: $1.09M2011: $774.0K2012: $339.7K2013: $898.2K2014: $3.36M2015: $4.37M2016: $2.49M2017: $3.34M2018: $3.06M2019: $3.49M2020: $6.42M2021: $29.13M2022: $12.36M2023: $915.0K2024: $1.27M2025: $1.24M$1.24M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$1.24M-2.1%
2024$1.27M+38.9%
2023$915.0K-92.6%
2022$12.36M-57.6%
2021$29.13M+353.9%
2020$6.42M+83.8%
2019$3.49M+14.3%
2018$3.06M-8.5%
2017$3.34M+34.2%
2016$2.49M-43.0%
2015$4.37M+30.0%
2014$3.36M+274.2%
2013$898.2K+164.4%
2012$339.7K-56.1%
2011$774.0K-29.3%
2010$1.09M-24.6%
2009$1.45M—